Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 0.58 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13213912 | 1.00 | FAAH (0.58) | FAAHASAH1MEN1KMT2AKDM4E | |
| SCHEMBL14253316 | 1.00 | FAAH (0.58) | FAAHASAH1MEN1KMT2AKDM4E | |
| SCHEMBL9061545 | 1.00 | FAAH (0.58) | FAAHASAH1MEN1KMT2AKDM4E | |
| SCHEMBL26393717 | 1.00 | FAAH (0.58) | FAAHASAH1MEN1KMT2AKDM4E | |
| SCHEMBL11310187 | 1.00 | FAAH (0.58) | FAAHASAH1MEN1KMT2AKDM4E | |
| SCHEMBL24339916 | 1.00 | FAAH (0.58) | FAAHASAH1MEN1KMT2AKDM4E | |
| SCHEMBL5410583 | 1.00 | FAAH (0.58) | FAAHASAH1MEN1KMT2AKDM4E | |
| SCHEMBL1004187 | 1.00 | FAAH (0.58) | FAAHASAH1MEN1KMT2AKDM4E | |
| SCHEMBL22067566 | 1.00 | FAAH (0.58) | FAAHASAH1MEN1KMT2AKDM4E | |
| SCHEMBL23799216 | 0.98 | FAAH (0.55) | FAAHASAH1MEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116322759-A | Phospholipid compounds and uses thereof | 吉利德科学公司 | 2023-06-23 | — | — | CN | disclosed |
| US-9359585-B2 | Stable nonaqueous reactive skin care and cleansing compositions having a continuous and a discontinuous phase | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2016-06-07 | — | — | US | disclosed |
| US-8986721-B2 | Personal care implement containing a stable reactive skin care and cleansing composition | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) | 2015-03-24 | — | — | US | disclosed |
| US-20130118518-A1 | Personal Care Implement Containing a Stable Reactive Skin Care and Cleansing Composition | CONOPCO, INC., D/B/A UNILEVER (US) | 2013-05-16 | — | — | US | disclosed |
| US-8357383-B2 | Personal care implement containing a stable reactive skin care and cleansing composition | CONOPCO, INC. (US) | 2013-01-22 | — | — | US | disclosed |
| US-20110014253-A1 | PERSONAL CARE IMPLEMENT CONTAINING A STABLE REACTIVE SKIN CARE AND CLEANSING COMPOSITION | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2011-01-20 | — | — | US | disclosed |
| US-7846462-B2 | Has a continuous and a discontinuous phase | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. (US) | 2010-12-07 | — | — | US | disclosed |
| US-7344868-B2 | Method for synthesizing ceramide-type compounds | LASSALLE LAURENT | 2008-03-18 | — | — | US | disclosed |
| US-7344868-B2 | Method for synthesizing ceramide-type compounds | LASSALLE LAURENT | 2008-03-18 | — | — | US | disclosed |
| EP-1696862-A1 | PERSONAL CARE IMPLEMENT CONTAINING A STABLE REACTIVE SKIN CARE AND CLEANSING COMPOSITION | Unilever Plc (GB) | 2006-09-06 | — | — | EP | disclosed |
| EP-1691768-A2 | STABLE NON-AQUEOUS REACTIVE SKIN CARE AND CLEANSING COMPOSITIONS HAVING A CONTINUOUS AND A DISCONTINUOUS PHASE | Unilever Plc (GB) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005063192-A1 | PERSONAL CARE IMPLEMENT CONTAINING A STABLE REACTIVE SKIN CARE AND CLEANSING COMPOSITION | UNILEVER PLC (GB) | 2005-07-14 | — | — | WO | disclosed |
| WO-2005058271-A2 | STABLE NON-AQUEOUS REACTIVE SKIN CARE AND CLEANSING COMPOSITIONS HAVING A CONTINUOUS AND A DISCONTINUOUS PHASE | UNILEVER PLC (GB) | 2005-06-30 | — | — | WO | disclosed |
| US-20050136098-A1 | Has a continuous and a discontinuous phase | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2005-06-23 | — | — | US | disclosed |
| US-20050123573-A1 | Stable nonaqueous reactive skin care and cleansing compositions having a continuous and a discontinuous phase | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2005-06-09 | — | — | US | disclosed |
| EP-0702556-B1 | (PHOSPHO)LIPIDS FOR COMBATTING HEPATITIS B VIRUS INFECTION | UNIV WAKE FOREST (US) | 2002-10-23 | — | — | EP | disclosed |
| US-6030960-A | INHIBITING THE PRODUCTION OF HEPATITIS VIRUS-INDUCED ANTIGENS IN A HUMAN SUBJECT BY ADMINISTERING A COMPOUND | WAKE FOREST UNIVERSITY (US) | 2000-02-29 | — | — | US | disclosed |
| US-5770584-A | ADMINISTERING AN ALKYL LIPID OR ALKYL LIPID DERIVATIVE VIRICIDES | WAKE FOREST UNIVERSITY (US) | 1998-06-23 | — | — | US | disclosed |
| US-5762910-A | CONTRAST AGENT COMPRISING COMPLEX OF PARAMAGNETIC ION AND COMPOUND BEARING LONG ACYL CHAIN | IMARX PHARMACEUTICAL CORP. (US) | 1998-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136098-A1 | Has a continuous and a discontinuous phase | CUTA, POLR1C, POLQ | FAAH 1479/4885ASAH1 807/4885MEN1 4377/4885 |
| US-20110014253-A1 | PERSONAL CARE IMPLEMENT CONTAINING A STABLE REACTIVE SKIN CARE AND CLEANSING COMPOSITION | CUTA, POLR1C, DSG1 | FAAH 2882/4885ASAH1 2417/4885MEN1 4002/4885 |
| US-20050123573-A1 | Stable nonaqueous reactive skin care and cleansing compositions having a continuous and a discontinuous phase | CUTA, POLR1C, POLQ | FAAH 1326/4885ASAH1 919/4885MEN1 4765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.